Global PD-1 and PD-L1 Inhibitor Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global PD-1 and PD-L1 Inhibitor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 and PD-L1 Inhibitor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 and PD-L1 Inhibitor market in any manner.
Global PD-1 and PD-L1 Inhibitor Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Bristol-Myers Squibb
Pfizer
Sanofi
Regeneron Pharmaceuticals
Roche
AstraZeneca
Bristol Myers Squibb
Hengrui Medicine
Beigene
Innovent Biologics
Junshi Biosciences
Akeso
Alphamab Oncology
Market Segmentation (by Type)
Monoclonal Antibody
Bispecific Antibody
Market Segmentation (by Application)
Lung Cancer
Stomach Cancer
Breast Cancer
Rectal Cancer
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-1 and PD-L1 Inhibitor Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global PD-1 and PD-L1 Inhibitor market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 and PD-L1 Inhibitor Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 and PD-L1 Inhibitor market in any manner.
Global PD-1 and PD-L1 Inhibitor Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Bristol-Myers Squibb
Pfizer
Sanofi
Regeneron Pharmaceuticals
Roche
AstraZeneca
Bristol Myers Squibb
Hengrui Medicine
Beigene
Innovent Biologics
Junshi Biosciences
Akeso
Alphamab Oncology
Market Segmentation (by Type)
Monoclonal Antibody
Bispecific Antibody
Market Segmentation (by Application)
Lung Cancer
Stomach Cancer
Breast Cancer
Rectal Cancer
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the PD-1 and PD-L1 Inhibitor Market
- Overview of the regional outlook of the PD-1 and PD-L1 Inhibitor Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-1 and PD-L1 Inhibitor Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of PD-1 and PD-L1 Inhibitor
1.2 Key Market Segments
1.2.1 PD-1 and PD-L1 Inhibitor Segment by Type
1.2.2 PD-1 and PD-L1 Inhibitor Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 AND PD-L1 INHIBITOR MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-1 and PD-L1 Inhibitor Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 and PD-L1 Inhibitor Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 AND PD-L1 INHIBITOR MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-1 and PD-L1 Inhibitor Sales by Manufacturers (2019-2024)
3.2 Global PD-1 and PD-L1 Inhibitor Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 and PD-L1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PD-L1 Inhibitor Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 and PD-L1 Inhibitor Sales Sites, Area Served, Product Type
3.6 PD-1 and PD-L1 Inhibitor Market Competitive Situation and Trends
3.6.1 PD-1 and PD-L1 Inhibitor Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PD-L1 Inhibitor Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 AND PD-L1 INHIBITOR INDUSTRY CHAIN ANALYSIS
4.1 PD-1 and PD-L1 Inhibitor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-1 AND PD-L1 INHIBITOR MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 AND PD-L1 INHIBITOR MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PD-L1 Inhibitor Sales Market Share by Type (2019-2024)
6.3 Global PD-1 and PD-L1 Inhibitor Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 and PD-L1 Inhibitor Price by Type (2019-2024)
7 PD-1 AND PD-L1 INHIBITOR MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PD-L1 Inhibitor Market Sales by Application (2019-2024)
7.3 Global PD-1 and PD-L1 Inhibitor Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 and PD-L1 Inhibitor Sales Growth Rate by Application (2019-2024)
8 PD-1 AND PD-L1 INHIBITOR MARKET SEGMENTATION BY REGION
8.1 Global PD-1 and PD-L1 Inhibitor Sales by Region
8.1.1 Global PD-1 and PD-L1 Inhibitor Sales by Region
8.1.2 Global PD-1 and PD-L1 Inhibitor Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PD-L1 Inhibitor Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PD-L1 Inhibitor Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PD-L1 Inhibitor Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PD-L1 Inhibitor Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PD-L1 Inhibitor Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck PD-1 and PD-L1 Inhibitor Basic Information
9.1.2 Merck PD-1 and PD-L1 Inhibitor Product Overview
9.1.3 Merck PD-1 and PD-L1 Inhibitor Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck PD-1 and PD-L1 Inhibitor SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Basic Information
9.2.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product Overview
9.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product Market Performance
9.2.4 Bristol-Myers Squibb Business Overview
9.2.5 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor SWOT Analysis
9.2.6 Bristol-Myers Squibb Recent Developments
9.3 Pfizer
9.3.1 Pfizer PD-1 and PD-L1 Inhibitor Basic Information
9.3.2 Pfizer PD-1 and PD-L1 Inhibitor Product Overview
9.3.3 Pfizer PD-1 and PD-L1 Inhibitor Product Market Performance
9.3.4 Pfizer PD-1 and PD-L1 Inhibitor SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Sanofi
9.4.1 Sanofi PD-1 and PD-L1 Inhibitor Basic Information
9.4.2 Sanofi PD-1 and PD-L1 Inhibitor Product Overview
9.4.3 Sanofi PD-1 and PD-L1 Inhibitor Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Regeneron Pharmaceuticals
9.5.1 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Basic Information
9.5.2 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product Overview
9.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product Market Performance
9.5.4 Regeneron Pharmaceuticals Business Overview
9.5.5 Regeneron Pharmaceuticals Recent Developments
9.6 Roche
9.6.1 Roche PD-1 and PD-L1 Inhibitor Basic Information
9.6.2 Roche PD-1 and PD-L1 Inhibitor Product Overview
9.6.3 Roche PD-1 and PD-L1 Inhibitor Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca PD-1 and PD-L1 Inhibitor Basic Information
9.7.2 AstraZeneca PD-1 and PD-L1 Inhibitor Product Overview
9.7.3 AstraZeneca PD-1 and PD-L1 Inhibitor Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Bristol Myers Squibb
9.8.1 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Basic Information
9.8.2 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product Overview
9.8.3 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product Market Performance
9.8.4 Bristol Myers Squibb Business Overview
9.8.5 Bristol Myers Squibb Recent Developments
9.9 Hengrui Medicine
9.9.1 Hengrui Medicine PD-1 and PD-L1 Inhibitor Basic Information
9.9.2 Hengrui Medicine PD-1 and PD-L1 Inhibitor Product Overview
9.9.3 Hengrui Medicine PD-1 and PD-L1 Inhibitor Product Market Performance
9.9.4 Hengrui Medicine Business Overview
9.9.5 Hengrui Medicine Recent Developments
9.10 Beigene
9.10.1 Beigene PD-1 and PD-L1 Inhibitor Basic Information
9.10.2 Beigene PD-1 and PD-L1 Inhibitor Product Overview
9.10.3 Beigene PD-1 and PD-L1 Inhibitor Product Market Performance
9.10.4 Beigene Business Overview
9.10.5 Beigene Recent Developments
9.11 Innovent Biologics
9.11.1 Innovent Biologics PD-1 and PD-L1 Inhibitor Basic Information
9.11.2 Innovent Biologics PD-1 and PD-L1 Inhibitor Product Overview
9.11.3 Innovent Biologics PD-1 and PD-L1 Inhibitor Product Market Performance
9.11.4 Innovent Biologics Business Overview
9.11.5 Innovent Biologics Recent Developments
9.12 Junshi Biosciences
9.12.1 Junshi Biosciences PD-1 and PD-L1 Inhibitor Basic Information
9.12.2 Junshi Biosciences PD-1 and PD-L1 Inhibitor Product Overview
9.12.3 Junshi Biosciences PD-1 and PD-L1 Inhibitor Product Market Performance
9.12.4 Junshi Biosciences Business Overview
9.12.5 Junshi Biosciences Recent Developments
9.13 Akeso
9.13.1 Akeso PD-1 and PD-L1 Inhibitor Basic Information
9.13.2 Akeso PD-1 and PD-L1 Inhibitor Product Overview
9.13.3 Akeso PD-1 and PD-L1 Inhibitor Product Market Performance
9.13.4 Akeso Business Overview
9.13.5 Akeso Recent Developments
9.14 Alphamab Oncology
9.14.1 Alphamab Oncology PD-1 and PD-L1 Inhibitor Basic Information
9.14.2 Alphamab Oncology PD-1 and PD-L1 Inhibitor Product Overview
9.14.3 Alphamab Oncology PD-1 and PD-L1 Inhibitor Product Market Performance
9.14.4 Alphamab Oncology Business Overview
9.14.5 Alphamab Oncology Recent Developments
10 PD-1 AND PD-L1 INHIBITOR MARKET FORECAST BY REGION
10.1 Global PD-1 and PD-L1 Inhibitor Market Size Forecast
10.2 Global PD-1 and PD-L1 Inhibitor Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 and PD-L1 Inhibitor Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 and PD-L1 Inhibitor Market Size Forecast by Region
10.2.4 South America PD-1 and PD-L1 Inhibitor Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PD-L1 Inhibitor by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-1 and PD-L1 Inhibitor Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitor by Type (2025-2030)
11.1.2 Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 and PD-L1 Inhibitor by Type (2025-2030)
11.2 Global PD-1 and PD-L1 Inhibitor Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) Forecast by Application
11.2.2 Global PD-1 and PD-L1 Inhibitor Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of PD-1 and PD-L1 Inhibitor
1.2 Key Market Segments
1.2.1 PD-1 and PD-L1 Inhibitor Segment by Type
1.2.2 PD-1 and PD-L1 Inhibitor Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 AND PD-L1 INHIBITOR MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-1 and PD-L1 Inhibitor Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 and PD-L1 Inhibitor Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 AND PD-L1 INHIBITOR MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-1 and PD-L1 Inhibitor Sales by Manufacturers (2019-2024)
3.2 Global PD-1 and PD-L1 Inhibitor Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 and PD-L1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PD-L1 Inhibitor Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 and PD-L1 Inhibitor Sales Sites, Area Served, Product Type
3.6 PD-1 and PD-L1 Inhibitor Market Competitive Situation and Trends
3.6.1 PD-1 and PD-L1 Inhibitor Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PD-L1 Inhibitor Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 AND PD-L1 INHIBITOR INDUSTRY CHAIN ANALYSIS
4.1 PD-1 and PD-L1 Inhibitor Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-1 AND PD-L1 INHIBITOR MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 AND PD-L1 INHIBITOR MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PD-L1 Inhibitor Sales Market Share by Type (2019-2024)
6.3 Global PD-1 and PD-L1 Inhibitor Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 and PD-L1 Inhibitor Price by Type (2019-2024)
7 PD-1 AND PD-L1 INHIBITOR MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PD-L1 Inhibitor Market Sales by Application (2019-2024)
7.3 Global PD-1 and PD-L1 Inhibitor Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 and PD-L1 Inhibitor Sales Growth Rate by Application (2019-2024)
8 PD-1 AND PD-L1 INHIBITOR MARKET SEGMENTATION BY REGION
8.1 Global PD-1 and PD-L1 Inhibitor Sales by Region
8.1.1 Global PD-1 and PD-L1 Inhibitor Sales by Region
8.1.2 Global PD-1 and PD-L1 Inhibitor Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PD-L1 Inhibitor Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PD-L1 Inhibitor Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PD-L1 Inhibitor Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PD-L1 Inhibitor Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PD-L1 Inhibitor Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck PD-1 and PD-L1 Inhibitor Basic Information
9.1.2 Merck PD-1 and PD-L1 Inhibitor Product Overview
9.1.3 Merck PD-1 and PD-L1 Inhibitor Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck PD-1 and PD-L1 Inhibitor SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Basic Information
9.2.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product Overview
9.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product Market Performance
9.2.4 Bristol-Myers Squibb Business Overview
9.2.5 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor SWOT Analysis
9.2.6 Bristol-Myers Squibb Recent Developments
9.3 Pfizer
9.3.1 Pfizer PD-1 and PD-L1 Inhibitor Basic Information
9.3.2 Pfizer PD-1 and PD-L1 Inhibitor Product Overview
9.3.3 Pfizer PD-1 and PD-L1 Inhibitor Product Market Performance
9.3.4 Pfizer PD-1 and PD-L1 Inhibitor SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Sanofi
9.4.1 Sanofi PD-1 and PD-L1 Inhibitor Basic Information
9.4.2 Sanofi PD-1 and PD-L1 Inhibitor Product Overview
9.4.3 Sanofi PD-1 and PD-L1 Inhibitor Product Market Performance
9.4.4 Sanofi Business Overview
9.4.5 Sanofi Recent Developments
9.5 Regeneron Pharmaceuticals
9.5.1 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Basic Information
9.5.2 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product Overview
9.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product Market Performance
9.5.4 Regeneron Pharmaceuticals Business Overview
9.5.5 Regeneron Pharmaceuticals Recent Developments
9.6 Roche
9.6.1 Roche PD-1 and PD-L1 Inhibitor Basic Information
9.6.2 Roche PD-1 and PD-L1 Inhibitor Product Overview
9.6.3 Roche PD-1 and PD-L1 Inhibitor Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca PD-1 and PD-L1 Inhibitor Basic Information
9.7.2 AstraZeneca PD-1 and PD-L1 Inhibitor Product Overview
9.7.3 AstraZeneca PD-1 and PD-L1 Inhibitor Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Bristol Myers Squibb
9.8.1 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Basic Information
9.8.2 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product Overview
9.8.3 Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product Market Performance
9.8.4 Bristol Myers Squibb Business Overview
9.8.5 Bristol Myers Squibb Recent Developments
9.9 Hengrui Medicine
9.9.1 Hengrui Medicine PD-1 and PD-L1 Inhibitor Basic Information
9.9.2 Hengrui Medicine PD-1 and PD-L1 Inhibitor Product Overview
9.9.3 Hengrui Medicine PD-1 and PD-L1 Inhibitor Product Market Performance
9.9.4 Hengrui Medicine Business Overview
9.9.5 Hengrui Medicine Recent Developments
9.10 Beigene
9.10.1 Beigene PD-1 and PD-L1 Inhibitor Basic Information
9.10.2 Beigene PD-1 and PD-L1 Inhibitor Product Overview
9.10.3 Beigene PD-1 and PD-L1 Inhibitor Product Market Performance
9.10.4 Beigene Business Overview
9.10.5 Beigene Recent Developments
9.11 Innovent Biologics
9.11.1 Innovent Biologics PD-1 and PD-L1 Inhibitor Basic Information
9.11.2 Innovent Biologics PD-1 and PD-L1 Inhibitor Product Overview
9.11.3 Innovent Biologics PD-1 and PD-L1 Inhibitor Product Market Performance
9.11.4 Innovent Biologics Business Overview
9.11.5 Innovent Biologics Recent Developments
9.12 Junshi Biosciences
9.12.1 Junshi Biosciences PD-1 and PD-L1 Inhibitor Basic Information
9.12.2 Junshi Biosciences PD-1 and PD-L1 Inhibitor Product Overview
9.12.3 Junshi Biosciences PD-1 and PD-L1 Inhibitor Product Market Performance
9.12.4 Junshi Biosciences Business Overview
9.12.5 Junshi Biosciences Recent Developments
9.13 Akeso
9.13.1 Akeso PD-1 and PD-L1 Inhibitor Basic Information
9.13.2 Akeso PD-1 and PD-L1 Inhibitor Product Overview
9.13.3 Akeso PD-1 and PD-L1 Inhibitor Product Market Performance
9.13.4 Akeso Business Overview
9.13.5 Akeso Recent Developments
9.14 Alphamab Oncology
9.14.1 Alphamab Oncology PD-1 and PD-L1 Inhibitor Basic Information
9.14.2 Alphamab Oncology PD-1 and PD-L1 Inhibitor Product Overview
9.14.3 Alphamab Oncology PD-1 and PD-L1 Inhibitor Product Market Performance
9.14.4 Alphamab Oncology Business Overview
9.14.5 Alphamab Oncology Recent Developments
10 PD-1 AND PD-L1 INHIBITOR MARKET FORECAST BY REGION
10.1 Global PD-1 and PD-L1 Inhibitor Market Size Forecast
10.2 Global PD-1 and PD-L1 Inhibitor Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 and PD-L1 Inhibitor Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 and PD-L1 Inhibitor Market Size Forecast by Region
10.2.4 South America PD-1 and PD-L1 Inhibitor Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PD-L1 Inhibitor by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-1 and PD-L1 Inhibitor Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitor by Type (2025-2030)
11.1.2 Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 and PD-L1 Inhibitor by Type (2025-2030)
11.2 Global PD-1 and PD-L1 Inhibitor Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) Forecast by Application
11.2.2 Global PD-1 and PD-L1 Inhibitor Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 and PD-L1 Inhibitor Market Size Comparison by Region (M USD)
Table 5. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 and PD-L1 Inhibitor Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 and PD-L1 Inhibitor Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitor as of 2022)
Table 10. Global Market PD-1 and PD-L1 Inhibitor Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 and PD-L1 Inhibitor Sales Sites and Area Served
Table 12. Manufacturers PD-1 and PD-L1 Inhibitor Product Type
Table 13. Global PD-1 and PD-L1 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 and PD-L1 Inhibitor
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 and PD-L1 Inhibitor Market Challenges
Table 22. Global PD-1 and PD-L1 Inhibitor Sales by Type (Kilotons)
Table 23. Global PD-1 and PD-L1 Inhibitor Market Size by Type (M USD)
Table 24. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) by Type (2019-2024)
Table 25. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 and PD-L1 Inhibitor Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 and PD-L1 Inhibitor Market Size Share by Type (2019-2024)
Table 28. Global PD-1 and PD-L1 Inhibitor Price (USD/Ton) by Type (2019-2024)
Table 29. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) by Application
Table 30. Global PD-1 and PD-L1 Inhibitor Market Size by Application
Table 31. Global PD-1 and PD-L1 Inhibitor Sales by Application (2019-2024) & (Kilotons)
Table 32. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 and PD-L1 Inhibitor Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 and PD-L1 Inhibitor Market Share by Application (2019-2024)
Table 35. Global PD-1 and PD-L1 Inhibitor Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 and PD-L1 Inhibitor Sales by Region (2019-2024) & (Kilotons)
Table 37. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 and PD-L1 Inhibitor Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe PD-1 and PD-L1 Inhibitor Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific PD-1 and PD-L1 Inhibitor Sales by Region (2019-2024) & (Kilotons)
Table 41. South America PD-1 and PD-L1 Inhibitor Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa PD-1 and PD-L1 Inhibitor Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck PD-1 and PD-L1 Inhibitor Basic Information
Table 44. Merck PD-1 and PD-L1 Inhibitor Product Overview
Table 45. Merck PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck PD-1 and PD-L1 Inhibitor SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Basic Information
Table 50. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product Overview
Table 51. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor SWOT Analysis
Table 54. Bristol-Myers Squibb Recent Developments
Table 55. Pfizer PD-1 and PD-L1 Inhibitor Basic Information
Table 56. Pfizer PD-1 and PD-L1 Inhibitor Product Overview
Table 57. Pfizer PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer PD-1 and PD-L1 Inhibitor SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Sanofi PD-1 and PD-L1 Inhibitor Basic Information
Table 62. Sanofi PD-1 and PD-L1 Inhibitor Product Overview
Table 63. Sanofi PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Business Overview
Table 65. Sanofi Recent Developments
Table 66. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Basic Information
Table 67. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product Overview
Table 68. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Regeneron Pharmaceuticals Business Overview
Table 70. Regeneron Pharmaceuticals Recent Developments
Table 71. Roche PD-1 and PD-L1 Inhibitor Basic Information
Table 72. Roche PD-1 and PD-L1 Inhibitor Product Overview
Table 73. Roche PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. AstraZeneca PD-1 and PD-L1 Inhibitor Basic Information
Table 77. AstraZeneca PD-1 and PD-L1 Inhibitor Product Overview
Table 78. AstraZeneca PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Basic Information
Table 82. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product Overview
Table 83. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bristol Myers Squibb Business Overview
Table 85. Bristol Myers Squibb Recent Developments
Table 86. Hengrui Medicine PD-1 and PD-L1 Inhibitor Basic Information
Table 87. Hengrui Medicine PD-1 and PD-L1 Inhibitor Product Overview
Table 88. Hengrui Medicine PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hengrui Medicine Business Overview
Table 90. Hengrui Medicine Recent Developments
Table 91. Beigene PD-1 and PD-L1 Inhibitor Basic Information
Table 92. Beigene PD-1 and PD-L1 Inhibitor Product Overview
Table 93. Beigene PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Beigene Business Overview
Table 95. Beigene Recent Developments
Table 96. Innovent Biologics PD-1 and PD-L1 Inhibitor Basic Information
Table 97. Innovent Biologics PD-1 and PD-L1 Inhibitor Product Overview
Table 98. Innovent Biologics PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Innovent Biologics Business Overview
Table 100. Innovent Biologics Recent Developments
Table 101. Junshi Biosciences PD-1 and PD-L1 Inhibitor Basic Information
Table 102. Junshi Biosciences PD-1 and PD-L1 Inhibitor Product Overview
Table 103. Junshi Biosciences PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Junshi Biosciences Business Overview
Table 105. Junshi Biosciences Recent Developments
Table 106. Akeso PD-1 and PD-L1 Inhibitor Basic Information
Table 107. Akeso PD-1 and PD-L1 Inhibitor Product Overview
Table 108. Akeso PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Akeso Business Overview
Table 110. Akeso Recent Developments
Table 111. Alphamab Oncology PD-1 and PD-L1 Inhibitor Basic Information
Table 112. Alphamab Oncology PD-1 and PD-L1 Inhibitor Product Overview
Table 113. Alphamab Oncology PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Alphamab Oncology Business Overview
Table 115. Alphamab Oncology Recent Developments
Table 116. Global PD-1 and PD-L1 Inhibitor Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America PD-1 and PD-L1 Inhibitor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America PD-1 and PD-L1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe PD-1 and PD-L1 Inhibitor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe PD-1 and PD-L1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific PD-1 and PD-L1 Inhibitor Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific PD-1 and PD-L1 Inhibitor Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America PD-1 and PD-L1 Inhibitor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America PD-1 and PD-L1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa PD-1 and PD-L1 Inhibitor Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa PD-1 and PD-L1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global PD-1 and PD-L1 Inhibitor Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global PD-1 and PD-L1 Inhibitor Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 and PD-L1 Inhibitor Market Size Comparison by Region (M USD)
Table 5. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 and PD-L1 Inhibitor Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 and PD-L1 Inhibitor Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitor as of 2022)
Table 10. Global Market PD-1 and PD-L1 Inhibitor Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 and PD-L1 Inhibitor Sales Sites and Area Served
Table 12. Manufacturers PD-1 and PD-L1 Inhibitor Product Type
Table 13. Global PD-1 and PD-L1 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 and PD-L1 Inhibitor
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 and PD-L1 Inhibitor Market Challenges
Table 22. Global PD-1 and PD-L1 Inhibitor Sales by Type (Kilotons)
Table 23. Global PD-1 and PD-L1 Inhibitor Market Size by Type (M USD)
Table 24. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) by Type (2019-2024)
Table 25. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 and PD-L1 Inhibitor Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 and PD-L1 Inhibitor Market Size Share by Type (2019-2024)
Table 28. Global PD-1 and PD-L1 Inhibitor Price (USD/Ton) by Type (2019-2024)
Table 29. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) by Application
Table 30. Global PD-1 and PD-L1 Inhibitor Market Size by Application
Table 31. Global PD-1 and PD-L1 Inhibitor Sales by Application (2019-2024) & (Kilotons)
Table 32. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 and PD-L1 Inhibitor Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 and PD-L1 Inhibitor Market Share by Application (2019-2024)
Table 35. Global PD-1 and PD-L1 Inhibitor Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 and PD-L1 Inhibitor Sales by Region (2019-2024) & (Kilotons)
Table 37. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 and PD-L1 Inhibitor Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe PD-1 and PD-L1 Inhibitor Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific PD-1 and PD-L1 Inhibitor Sales by Region (2019-2024) & (Kilotons)
Table 41. South America PD-1 and PD-L1 Inhibitor Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa PD-1 and PD-L1 Inhibitor Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck PD-1 and PD-L1 Inhibitor Basic Information
Table 44. Merck PD-1 and PD-L1 Inhibitor Product Overview
Table 45. Merck PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck PD-1 and PD-L1 Inhibitor SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Basic Information
Table 50. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Product Overview
Table 51. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitor SWOT Analysis
Table 54. Bristol-Myers Squibb Recent Developments
Table 55. Pfizer PD-1 and PD-L1 Inhibitor Basic Information
Table 56. Pfizer PD-1 and PD-L1 Inhibitor Product Overview
Table 57. Pfizer PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pfizer PD-1 and PD-L1 Inhibitor SWOT Analysis
Table 59. Pfizer Business Overview
Table 60. Pfizer Recent Developments
Table 61. Sanofi PD-1 and PD-L1 Inhibitor Basic Information
Table 62. Sanofi PD-1 and PD-L1 Inhibitor Product Overview
Table 63. Sanofi PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sanofi Business Overview
Table 65. Sanofi Recent Developments
Table 66. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Basic Information
Table 67. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Product Overview
Table 68. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Regeneron Pharmaceuticals Business Overview
Table 70. Regeneron Pharmaceuticals Recent Developments
Table 71. Roche PD-1 and PD-L1 Inhibitor Basic Information
Table 72. Roche PD-1 and PD-L1 Inhibitor Product Overview
Table 73. Roche PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. AstraZeneca PD-1 and PD-L1 Inhibitor Basic Information
Table 77. AstraZeneca PD-1 and PD-L1 Inhibitor Product Overview
Table 78. AstraZeneca PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Recent Developments
Table 81. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Basic Information
Table 82. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Product Overview
Table 83. Bristol Myers Squibb PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bristol Myers Squibb Business Overview
Table 85. Bristol Myers Squibb Recent Developments
Table 86. Hengrui Medicine PD-1 and PD-L1 Inhibitor Basic Information
Table 87. Hengrui Medicine PD-1 and PD-L1 Inhibitor Product Overview
Table 88. Hengrui Medicine PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hengrui Medicine Business Overview
Table 90. Hengrui Medicine Recent Developments
Table 91. Beigene PD-1 and PD-L1 Inhibitor Basic Information
Table 92. Beigene PD-1 and PD-L1 Inhibitor Product Overview
Table 93. Beigene PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Beigene Business Overview
Table 95. Beigene Recent Developments
Table 96. Innovent Biologics PD-1 and PD-L1 Inhibitor Basic Information
Table 97. Innovent Biologics PD-1 and PD-L1 Inhibitor Product Overview
Table 98. Innovent Biologics PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Innovent Biologics Business Overview
Table 100. Innovent Biologics Recent Developments
Table 101. Junshi Biosciences PD-1 and PD-L1 Inhibitor Basic Information
Table 102. Junshi Biosciences PD-1 and PD-L1 Inhibitor Product Overview
Table 103. Junshi Biosciences PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Junshi Biosciences Business Overview
Table 105. Junshi Biosciences Recent Developments
Table 106. Akeso PD-1 and PD-L1 Inhibitor Basic Information
Table 107. Akeso PD-1 and PD-L1 Inhibitor Product Overview
Table 108. Akeso PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Akeso Business Overview
Table 110. Akeso Recent Developments
Table 111. Alphamab Oncology PD-1 and PD-L1 Inhibitor Basic Information
Table 112. Alphamab Oncology PD-1 and PD-L1 Inhibitor Product Overview
Table 113. Alphamab Oncology PD-1 and PD-L1 Inhibitor Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Alphamab Oncology Business Overview
Table 115. Alphamab Oncology Recent Developments
Table 116. Global PD-1 and PD-L1 Inhibitor Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America PD-1 and PD-L1 Inhibitor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America PD-1 and PD-L1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe PD-1 and PD-L1 Inhibitor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe PD-1 and PD-L1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific PD-1 and PD-L1 Inhibitor Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific PD-1 and PD-L1 Inhibitor Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America PD-1 and PD-L1 Inhibitor Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America PD-1 and PD-L1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa PD-1 and PD-L1 Inhibitor Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa PD-1 and PD-L1 Inhibitor Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global PD-1 and PD-L1 Inhibitor Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global PD-1 and PD-L1 Inhibitor Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of PD-1 and PD-L1 Inhibitor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 and PD-L1 Inhibitor Market Size (M USD), 2019-2030
Figure 5. Global PD-1 and PD-L1 Inhibitor Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 and PD-L1 Inhibitor Market Size by Country (M USD)
Figure 11. PD-1 and PD-L1 Inhibitor Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 and PD-L1 Inhibitor Revenue Share by Manufacturers in 2023
Figure 13. PD-1 and PD-L1 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 and PD-L1 Inhibitor Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 and PD-L1 Inhibitor Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 and PD-L1 Inhibitor Market Share by Type
Figure 18. Sales Market Share of PD-1 and PD-L1 Inhibitor by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 and PD-L1 Inhibitor by Type in 2023
Figure 20. Market Size Share of PD-1 and PD-L1 Inhibitor by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 and PD-L1 Inhibitor by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 and PD-L1 Inhibitor Market Share by Application
Figure 24. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Application in 2023
Figure 26. Global PD-1 and PD-L1 Inhibitor Market Share by Application (2019-2024)
Figure 27. Global PD-1 and PD-L1 Inhibitor Market Share by Application in 2023
Figure 28. Global PD-1 and PD-L1 Inhibitor Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America PD-1 and PD-L1 Inhibitor Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada PD-1 and PD-L1 Inhibitor Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 and PD-L1 Inhibitor Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe PD-1 and PD-L1 Inhibitor Sales Market Share by Country in 2023
Figure 37. Germany PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific PD-1 and PD-L1 Inhibitor Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific PD-1 and PD-L1 Inhibitor Sales Market Share by Region in 2023
Figure 44. China PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America PD-1 and PD-L1 Inhibitor Sales and Growth Rate (Kilotons)
Figure 50. South America PD-1 and PD-L1 Inhibitor Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa PD-1 and PD-L1 Inhibitor Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa PD-1 and PD-L1 Inhibitor Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global PD-1 and PD-L1 Inhibitor Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 and PD-L1 Inhibitor Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 and PD-L1 Inhibitor Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 and PD-L1 Inhibitor Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 and PD-L1 Inhibitor Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of PD-1 and PD-L1 Inhibitor
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 and PD-L1 Inhibitor Market Size (M USD), 2019-2030
Figure 5. Global PD-1 and PD-L1 Inhibitor Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 and PD-L1 Inhibitor Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 and PD-L1 Inhibitor Market Size by Country (M USD)
Figure 11. PD-1 and PD-L1 Inhibitor Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 and PD-L1 Inhibitor Revenue Share by Manufacturers in 2023
Figure 13. PD-1 and PD-L1 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 and PD-L1 Inhibitor Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 and PD-L1 Inhibitor Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 and PD-L1 Inhibitor Market Share by Type
Figure 18. Sales Market Share of PD-1 and PD-L1 Inhibitor by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 and PD-L1 Inhibitor by Type in 2023
Figure 20. Market Size Share of PD-1 and PD-L1 Inhibitor by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 and PD-L1 Inhibitor by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 and PD-L1 Inhibitor Market Share by Application
Figure 24. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Application in 2023
Figure 26. Global PD-1 and PD-L1 Inhibitor Market Share by Application (2019-2024)
Figure 27. Global PD-1 and PD-L1 Inhibitor Market Share by Application in 2023
Figure 28. Global PD-1 and PD-L1 Inhibitor Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 and PD-L1 Inhibitor Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America PD-1 and PD-L1 Inhibitor Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada PD-1 and PD-L1 Inhibitor Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 and PD-L1 Inhibitor Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe PD-1 and PD-L1 Inhibitor Sales Market Share by Country in 2023
Figure 37. Germany PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific PD-1 and PD-L1 Inhibitor Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific PD-1 and PD-L1 Inhibitor Sales Market Share by Region in 2023
Figure 44. China PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America PD-1 and PD-L1 Inhibitor Sales and Growth Rate (Kilotons)
Figure 50. South America PD-1 and PD-L1 Inhibitor Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa PD-1 and PD-L1 Inhibitor Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa PD-1 and PD-L1 Inhibitor Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa PD-1 and PD-L1 Inhibitor Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global PD-1 and PD-L1 Inhibitor Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global PD-1 and PD-L1 Inhibitor Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 and PD-L1 Inhibitor Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 and PD-L1 Inhibitor Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 and PD-L1 Inhibitor Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 and PD-L1 Inhibitor Market Share Forecast by Application (2025-2030)
